CCCC · Forms 3, 4, 5
Insider trades at C4 Therapeutics, Inc.
No open-market insider buys or sells at C4 Therapeutics, Inc. in the last 90 days; 3 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for C4 Therapeutics, Inc. (CCCC) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Kenneth Carl Anderson | Director | Award | 3,662 | $3.14 | $11K | Form 4 | |
| Donna Roy Grogan | Director | Award | 4,618 | $3.14 | $15K | Form 4 | |
| Kendra Adams | Chief Financial Officer | Option exercise | 6,250 | Form 4 | |||
| Kendra Adams | Chief Financial Officer | Tax withholding | 2,775 | $3.39 | $9K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.